This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignees: Morphochem Aktiengesellschaft Fur Kombinatorische Chemie, Morphochem Aktiengesellschaft Für Kombinatorishe Chemie, Morphochem Gmbh. Active years: 2018-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 8 
1 out of 1 
1 out of 4 Years Active: 2018-2022
Title: Thomas Kapsner: Innovator in Antibacterial Treatments
Introduction
Thomas Kapsner is a notable inventor based in Gröbenzell, Germany. He has made significant contributions to the field of antibacterial treatments, holding a total of 3 patents. His work focuses on the development of innovative hybrid compounds that aim to improve the treatment and prophylaxis of bacterial diseases.
Latest Patents
Kapsner's latest patents include groundbreaking inventions related to oxazolidinone-quinolone hybrid antibacterials. One of his patents details the use of these hybrids for parenteral treatment, particularly intravenous administration, to combat bacterial diseases. This invention not only highlights the potential of oxazolidinone-quinolone hybrids but also introduces improved methods for their administration, enhancing their effectiveness in clinical settings.
Career Highlights
Throughout his career, Thomas Kapsner has worked with prominent companies in the pharmaceutical sector, including Morphochem Aktiengesellschaft für Kombinatorische Chemie and Morphochem GmbH. His experience in these organizations has allowed him to refine his expertise in medicinal chemistry and antibacterial research.
Collaborations
Kapsner has collaborated with notable professionals in his field, including Axel Dalhoff and Thomas Gramatte. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Thomas Kapsner's innovative work in the field of antibacterial treatments showcases his dedication to improving healthcare solutions. His patents reflect a commitment to advancing medical science and addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile